Strengthening Interactions Between CBER's Office of Tissues and Advanced Therapies and Cell and Gene Therapy Sponsors (CBER)

Generic Clearance for the Collection of Qualitative Feedback on Food and Drug Administration Service Delivery

OMB: 0910-0697

IC ID: 246467

Documents and Forms
Document Name
Document Type
Other-Invitation
Other-Invitation
Other-Interview Guide
Other-Interview Guide
IC Document
IC Document
Information Collection (IC) Details

View Information Collection (IC)

Strengthening Interactions Between CBER's Office of Tissues and Advanced Therapies and Cell and Gene Therapy Sponsors (CBER) CBER
 
Unchanged
 
Voluntary
 

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Invitation Appendix A - Invitation.docx Yes No Printable Only
Other-Interview Guide Appendix B - Sponsor Interview Guide.docx Yes No Printable Only

Health Health Care Services

 

30 0
   
Private Sector Businesses or other for-profits
 
   0 %

  Requested Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 30 0 0 0 0 30
Annual IC Time Burden (Hours) 45 0 0 0 0 45
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
OMB approval memo 0697 OMB Approval Memo - Interactions Between OTAT and CGT 2021.docx 03/26/2021
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.
© 2024 OMB.report | Privacy Policy